Trade

with

Achillion Pharmaceuticals Inc
(NASDAQ: ACHN)
AdChoices
11.71
+0.49
+4.37%
After Hours :
11.55
-0.16
-1.37%

Open

11.21

Previous Close

11.22

Volume (Avg)

4.12M (6.03M)

Day's Range

11.16-11.74

52Wk Range

2.26-13.80

Market Cap.

1.15B

Dividend Rate ( Yield )

-

Beta

2.33

Shares Outstanding

97.79M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 0

    • Net Income

    • -58.95M

    • Market Cap.

    • 1.15B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.33

    • Forward P/E

    • -14.18

    • Price/Sales

    • -

    • Price/Book Value

    • 9.09

    • Price/Cash flow

    • -19.69

      • EBITDA

      • -58.50M

      • Return on Capital %

      • -36.19

      • Return on Equity %

      • -38.97

      • Return on Assets %

      • -36.19

      • Book Value/Share

      • 1.29

      • Shares Outstanding

      • 97.79M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 18.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -0.69

        • Cashflow Estimate

        • -1.31

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 14.51

              • 2.92

              • Quick Ratio

              • 14.30

              • 2.35

              • Interest Coverage

              • -1,593.97

              • 38.02

              • Leverage Ratio

              • 1.07

              • 2.21

              • Book Value/Share

              • 1.29

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -18.15

                • 217.39

                • P/E Ratio 5-Year High

                • -22.64

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.41

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.52

                • Price/Book Value

                • 8.58

                • 8.61

                • Price/Cash Flow Ratio

                • -19.69

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -38.97

                        (-97.80)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -36.19

                        (-68.90)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -38.86

                        (-86.10)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -59.48M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -19.69
                      Ownership

                      Institutional Ownership

                      87.51%

                      Top 10 Institutions

                      54.39%

                      Mutual Fund Ownership

                      37.81%

                      Float

                      58.23%

                      5% / Insider Ownership

                      0.24%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        5,539,400

                      • 0.00

                      • 5.66

                      • VA CollegeAmerica Small Cap World

                      •  

                        4,930,000

                      • 19.37

                      • 5.04

                      • Goldman Sachs Small/Mid Cap Growth Fund

                      •  

                        1,543,122

                      • -9.57

                      • 1.58

                      • Vanguard Small Cap Index

                      •  

                        1,446,132

                      • 0.80

                      • 1.48

                      • iShares Russell 2000 (AU)

                      •  

                        1,436,068

                      • -1.46

                      • 1.65

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,350,468

                      • 0.00

                      • 1.38

                      • SPDR® S&P Biotech ETF

                      •  

                        1,285,547

                      • -1.92

                      • 1.48

                      • Bb Biotech AG

                      •  

                        1,279,340

                      • -28.10

                      • 1.31

                      • iShares Nasdaq Biotechnology

                      •  

                        1,265,119

                      • -0.47

                      • 1.45

                      • Pictet-Biotech

                      •  

                        1,220,502

                      • 0.07

                      • 3.03

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • RA Capital Management, LLC

                      •  

                        11,032,014

                      • -37.69%

                      • 11.28

                      • Fidelity Management and Research Company

                      •  

                        6,563,772

                      • +641.50%

                      • 6.71

                      • Qvt Financial LP

                      •  

                        5,109,153

                      • -53.42%

                      • 5.22

                      • Vanguard Group, Inc.

                      •  

                        4,889,994

                      • -4.47%

                      • 5.00

                      • Domain Partners VIII, LP

                      •  

                        4,572,968

                      • -20.79%

                      • 4.68

                      • Capital World Investors

                      •  

                        4,130,000

                      • 0.00%

                      • 4.22

                      • BlackRock Fund Advisors

                      •  

                        3,551,912

                      • -1.88%

                      • 3.63

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Achillion Pharmaceuticals Inc was incorporated on August 17, 1998 in Delaware. The Company is a biopharmaceutical company which focuses on the discoveries, develops and commercializes treatments for infectious diseases. Within the an...moreti-infective market, it is currently focusing its efforts on developing commercially competitive, short-duration combination therapies for the treatment of chronic hepatitis C infection that are administered once-daily, orally, and without ribavirin. The Company competes with Abbvie, Astra-Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Enanta, Gilead, GlaxoSmithKline, Idenix, Johnson & Johnson, Presidio, Medivir, Merck, Novartis, Pfizer, Roche, Valeant and Vertex. The Company's drug candidates is subject to extensive governmental regulations relating to, among other...more things, research, testing, development, manufacturing, safety, efficacy, record keeping, labeling, marketing and distribution of drugs.lessless

                      Key People

                      Milind S. Deshpande,PhD

                      CEO/President/Director

                      Mr. David I. Scheer

                      Chairman of the Board/Director

                      Mary Kay Fenton

                      CFO/Chief Accounting Officer/Executive VP/Secretary

                      Gautam Shah,PhD

                      Executive VP/Other Executive Officer

                      Joseph Truitt

                      Executive VP/Other Executive Officer

                      • Achillion Pharmaceuticals Inc

                      • 300 George Street

                      • New Haven, CT 06511

                      • USA.Map

                      • Phone: +1 203 724-6000

                      • Fax: +1 203 624-7003

                      • achillion.com

                      Incorporated

                      1998

                      Employees

                      62

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: